China Tian Yuan Healthcare Group Limited (HKG:0557)
Hong Kong · Delayed Price · Currency is HKD 0.6000
-0.0700 (-10.45%)
Jun 26, 2026, 3:51 PM HKT
HKG:0557 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 30.79 | 19.18 | 26.85 | 45.23 | 54.22 | 94.59 | |
Revenue Growth | 50.78% | -28.56% | -40.65% | -16.57% | -42.68% | 67.89% |
Cost of Revenue | 2.02 | -0.67 | 5.85 | 20.25 | 20.24 | 18.21 |
Gross Profit | 28.77 | 19.85 | 20.99 | 24.98 | 33.97 | 76.38 |
Selling, General & Admin | 29.65 | 31.07 | 31.1 | 40.75 | 56.63 | 90.03 |
Other Operating Expenses | -0.05 | - | - | - | - | - |
Operating Expenses | 33.93 | 31.93 | 28.36 | 47.8 | 56.58 | 93.8 |
Operating Income | -5.16 | -12.08 | -7.37 | -22.82 | -22.61 | -17.43 |
Interest Expense | -2.85 | -2.99 | -3.22 | -3.54 | -3.96 | -4.49 |
Interest & Investment Income | 0.58 | 0.61 | 0.74 | 0.15 | 0.03 | 0.01 |
Earnings From Equity Investments | -0.26 | -0.31 | -0.01 | -0.37 | 0.24 | 0.18 |
Currency Exchange Gain (Loss) | 2.89 | 2.58 | -2.51 | -3.9 | -5.03 | 1.07 |
Other Non Operating Income (Expenses) | 1.18 | 1.18 | 0.75 | 1.94 | 0.39 | 2.37 |
EBT Excluding Unusual Items | -3.62 | -11.01 | -11.63 | -28.54 | -30.93 | -18.28 |
Impairment of Goodwill | -27.25 | -27.25 | -23.47 | - | - | - |
Gain (Loss) on Sale of Investments | -0.97 | -0.81 | -3.26 | 1.7 | -6.93 | -0.67 |
Gain (Loss) on Sale of Assets | - | - | -0.07 | - | -0.02 | -0.11 |
Asset Writedown | - | - | - | -1.94 | -2.47 | - |
Pretax Income | -31.84 | -39.07 | -38.43 | -28.78 | -40.35 | -19.06 |
Income Tax Expense | -0.65 | -0.65 | 0.18 | -1.82 | - | - |
Earnings From Continuing Operations | -31.19 | -38.42 | -38.61 | -26.96 | -40.35 | -19.06 |
Net Income to Company | -31.19 | -38.42 | -38.61 | -26.96 | -40.35 | -19.06 |
Minority Interest in Earnings | 4.44 | 4.4 | 4.37 | 11.47 | 11.31 | 2.21 |
Net Income | -26.75 | -34.01 | -34.24 | -15.48 | -29.04 | -16.85 |
Net Income to Common | -26.75 | -34.01 | -34.24 | -15.48 | -29.04 | -16.85 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 399 | 399 | 399 | 399 | 399 | 399 |
Shares Outstanding (Diluted) | 399 | 399 | 399 | 399 | 399 | 399 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.07 | -0.09 | -0.09 | -0.04 | -0.07 | -0.04 |
EPS (Diluted) | -0.07 | -0.09 | -0.09 | -0.04 | -0.07 | -0.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 9.12 | 10.67 | 4.51 | -31.71 | 14.86 |
Free Cash Flow Per Share | - | 0.02 | 0.03 | 0.01 | -0.08 | 0.04 |
Gross Margin | 93.45% | 103.48% | 78.19% | 55.24% | 62.66% | 80.75% |
Operating Margin | -16.77% | -63.01% | -27.45% | -50.45% | -41.70% | -18.42% |
Profit Margin | -86.88% | -177.36% | -127.54% | -34.23% | -53.56% | -17.82% |
Free Cash Flow Margin | - | 47.54% | 39.76% | 9.96% | -58.49% | 15.71% |
EBITDA | -2.69 | -9.42 | -5 | -19.21 | -18.63 | -13.02 |
EBITDA Margin | -8.73% | -49.13% | -18.63% | -42.47% | -34.37% | -13.77% |
D&A For EBITDA | 2.48 | 2.66 | 2.37 | 3.61 | 3.98 | 4.4 |
EBIT | -5.16 | -12.08 | -7.37 | -22.82 | -22.61 | -17.43 |
EBIT Margin | -16.77% | -63.01% | -27.45% | -50.45% | -41.70% | -18.42% |